UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

Nature reviews cardiology, 2018-03, Vol.15 (3), p.151-166

2018

Volltextzugriff (PDF)

Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids

Current opinion in pharmacology, 2018-06, Vol.40, p.104-109

2018

Volltextzugriff (PDF)

Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease

European journal of pharmacology, 2021-03, Vol.895, p.173875, Article 173875

2021

Volltextzugriff (PDF)

In vitro cannabinoid activity profiling of generic ban‐evading brominated synthetic cannabinoid receptor agonists and their analogs

Drug testing and analysis, 2024-06, Vol.16 (6), p.616-628

2024

Volltextzugriff (PDF)

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays

Drug testing and analysis, 2021-07, Vol.13 (7), p.1412-1429

2021

Volltextzugriff (PDF)

First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201

European journal of clinical pharmacology, 2013-03, Vol.69 (3), p.373-376

2013

Volltextzugriff (PDF)

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

Drug and alcohol dependence, 2014-11, Vol.144, p.12-41

2014

Volltextzugriff (PDF)

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB 1 receptor activation assays-Part II: Structure activity relationship assessment via a β-arrestin recruitment assay

Drug testing and analysis, 2021-07, Vol.13 (7), p.1402-1411

2021

Volltextzugriff (PDF)

Novel Adamantyl Cannabinoids as CB1 Receptor Probes

Journal of medicinal chemistry, 2013-05, Vol.56 (10), p.3904-3921

2013

Volltextzugriff (PDF)

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB-4en-PICA, MDMB-4en-PINACA, ADB-4en-PINACA, and MMB-4CN-BUTINACA using a combination of binding and different CB 1 receptor activation assays: Part I-Synthesis, analytical characterization, and binding affinity for human CB 1 receptors

Drug testing and analysis, 2021-07, Vol.13 (7), p.1383-1401

2021

Volltextzugriff (PDF)

The synthetic CB 1 cannabinoid receptor selective agonists: Putative medical uses and their legalization

Progress in neuro-psychopharmacology & biological psychiatry, 2021-08, Vol.110, p.110301

2021

Volltextzugriff (PDF)

Synthetic Cannabinoid–Related Illnesses and Deaths

The New England journal of medicine, 2015-07, Vol.373 (2), p.103-107

2015

Volltextzugriff (PDF)

Spicing things up: synthetic cannabinoids

Psychopharmacology, 2013-08, Vol.228 (4), p.525-540

2013

Volltextzugriff (PDF)

Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis

Journal of medicinal chemistry, 2017-08, Vol.60 (16), p.7067-7083

2017

Volltextzugriff (PDF)

A new designer drug 5F-ADB activates midbrain dopaminergic neurons but not serotonergic neurons

The Journal of Toxicological Sciences, 2016/12/01, Vol.41(6), pp.813-816

2016

Volltextzugriff (PDF)

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists

Chemical reviews, 2016-01, Vol.116 (2), p.519-560

2016

Volltextzugriff (PDF)

Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences

The Journal of pharmacology and experimental therapeutics, 2017-04, Vol.361 (1), p.162-171

2017

Volltextzugriff (PDF)

Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample

Drug and alcohol dependence, 2013-07, Vol.131 (1), p.106-111

2013

Volltextzugriff (PDF)

A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment

Clinical toxicology (Philadelphia, Pa.), 2016-01, Vol.54 (1), p.1-13

2016

Volltextzugriff (PDF)

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

Scientific reports, 2016-02, Vol.6 (1), p.21703-21703, Article 21703

2016

Volltextzugriff (PDF)

Catalytic asymmetric synthesis of cannabinoids and menthol from neral

Nature (London), 2023-03, Vol.615 (7953), p.634-639

2023

Volltextzugriff (PDF)

An Outbreak of Synthetic Cannabinoid–Associated Coagulopathy in Illinois

The New England journal of medicine, 2018-09, Vol.379 (13), p.1216-1223

2018

Volltextzugriff (PDF)

Easy and Accessible Synthesis of Cannabinoids from CBD

Journal of natural products (Washington, D.C.), 2024-04, Vol.87 (4), p.869-875

2024

Volltextzugriff (PDF)

High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes

Clinical chemistry (Baltimore, Md.), 2016-01, Vol.62 (1), p.157-169

2016

Volltextzugriff (PDF)

Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA

ACS chemical neuroscience, 2017-08, Vol.8 (8), p.1673-1680

2017

Volltextzugriff (PDF)

1 – 25 von 707

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(680)
Mit Volltextzugriff
(625)

Publikationsform

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(583)
Life Sciences & Biomedicine
(536)
Humans
(424)
Animals
(422)
Pharmacology & Pharmacy
(407)
Chemistry, Medicinal
(334)
Structure-Activity Relationship
(313)
Chemistry
(235)
Physical Sciences
(223)
Biological And Medical Sciences
(212)
Cannabinoids - Chemical Synthesis
(205)
Medical Sciences
(205)
Rats
(202)
Pharmacology. Drug Treatments
(194)
Mice
(191)
Male
(160)
Ligands
(157)
Chemistry, Organic
(156)
Molecular Structure
(154)
Receptor, Cannabinoid, Cb1 - Metabolism
(152)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

Cannabis and joints: scientific evidence for the alleviation of osteoarthritis pain by cannabinoids

Analogues of cannabinoids as multitarget drugs in the treatment of Alzheimer's disease

In vitro cannabinoid activity profiling of generic ban‐evading brominated synthetic cannabinoid receptor agonists and their analogs

First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

Novel Adamantyl Cannabinoids as CB1 Receptor Probes

The synthetic CB 1 cannabinoid receptor selective agonists: Putative medical uses and their legalization

Synthetic Cannabinoid–Related Illnesses and Deaths

Spicing things up: synthetic cannabinoids

Amidoalkylindoles as Potent and Selective Cannabinoid Type 2 Receptor Agonists with in Vivo Efficacy in a Mouse Model of Multiple Sclerosis

A new designer drug 5F-ADB activates midbrain dopaminergic neurons but not serotonergic neurons

Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists

Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences

Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample

A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment

The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways

Catalytic asymmetric synthesis of cannabinoids and menthol from neral

An Outbreak of Synthetic Cannabinoid–Associated Coagulopathy in Illinois

Easy and Accessible Synthesis of Cannabinoids from CBD

High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes

Synthesis and Pharmacological Profiling of the Metabolites of Synthetic Cannabinoid Drugs APICA, STS-135, ADB-PINACA, and 5F-ADB-PINACA

Suchergebnisse filtern